Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Common Equity (2017 - 2026)

AdaptHealth has reported Common Equity over the past 9 years, most recently at $1.5 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 2.85% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, down 2.85%, while the annual FY2025 figure was $1.5 billion, 2.85% down from the prior year.
  • Common Equity for Q4 2025 was $1.5 billion at AdaptHealth, down from $1.6 billion in the prior quarter.
  • Over five years, Common Equity peaked at $2.2 billion in Q2 2023 and troughed at $1.5 billion in Q4 2023.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2021 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: surged 1970.36% in 2021 and later crashed 32.13% in 2024.
  • Year by year, Common Equity stood at $2.1 billion in 2021, then grew by 4.41% to $2.2 billion in 2022, then tumbled by 32.03% to $1.5 billion in 2023, then increased by 7.12% to $1.6 billion in 2024, then dropped by 2.85% to $1.5 billion in 2025.
  • Business Quant data shows Common Equity for AHCO at $1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.